Business

Aetna Profit Rises on Better Pricing, Strategy

Aetna Profit Rises on Better Pricing, Strategy

About 1,878 shares traded. A number of other institutional investors also recently bought and sold shares of the stock. Jaffetilchin Investment Partners LLC raised its position in Aetna by 11.1% in the second quarter. On average, equities analysts predict that Aetna Inc. will post $8.99 EPS for the current year. Stockholders of record on Thursday, July 13th were paid a $0.50 dividend.


Canadian Natural Resources profit tops estimates; cuts capex

Canadian Natural Resources profit tops estimates; cuts capex

A number of large investors have recently made changes to their positions in the company. Canadian Natural Resources Limited ( CNQ ) has the market capitalization of 36.89 Billion. The business had revenue of $1.63 billion for the quarter, compared to analysts' expectations of $1.06 billion. The Return on Equity (ROE) value stands at -3.2%.



Russian Federation says USA sanctions will not change anything

The president announced he signed the measure into law "for the sake of national unity", adding it "represents the will of the American people to see Russian Federation take steps to improve relations with the United States". Moscow rejects the charge it tried to swing the election in Trump's favor, and Trump denies his campaign had anything to do with such interference. "While I favour tough measures to punish and deter aggressive and destabilising behaviour by Iran, North Korea, and ...


Yum! Brands, Inc. (NYSE:YUM) Lifted to Buy at Zacks Investment Research

Yum! Brands, Inc. (NYSE:YUM) Lifted to Buy at Zacks Investment Research

I'm pleased Yum Brands' intensified focus on our four distinct growth drivers helped deliver another successful quarter. Morgan Stanley raised its position in Yum! Brands by 11.7% in the first quarter. If you are reading this story on another website, it was illegally copied and reposted in violation of worldwide trademark and copyright laws. The correct version of this article can be read at https://stocknewstimes.com/2017/08/03/spinnaker-trust-lowers-position-in-yum-brands-inc-yum.html.


Teva Pharmaceutical Industries Limited (NASDAQ:TEVA) To Report Earnings

Teva Pharmaceutical Industries Limited (NASDAQ:TEVA) To Report Earnings

About 6.96 million shares traded or 6.26% up from the average. Jefferies Group LLC restated a hold rating and set a $33.00 price objective on shares of Teva Pharmaceutical Industries Limited in a research report on Friday, June 23rd. Weaker prices in the States meant Teva reported an 18.4% drop in second quarter earnings to US$1.02 per share excluding one-off items (Q2 2016: US$5.7bn).